APO RESEARCH · REPORT
Encephalitis Vaccination
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
Product & engineering
Understand the product.
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
Selected research
Industry Research
Encephalitis Vaccination Industry Research Report 2026
Market perspective
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
Report Scope
Read the full market overview
This report quantifies the global Encephalitis Vaccination market in terms of revenue (US$ million) and, where applicable, sales volume (10K Person-time), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/10K Person-time) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Encephalitis Vaccination Market by Company
Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Beijing Taitan
Valneva
Bharat Biotech
Liaoning Chengda
Encephalitis Vaccination Segment by Type
Encephalitis B Vaccine
Encephalitis Attenuated Live Vaccine
Encephalitis Vaccination Segment by Application
Public Hospital
Private Hospital
Clinic
Other
Encephalitis Vaccination Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Encephalitis Vaccination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Encephalitis Vaccination and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Encephalitis Vaccination.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Encephalitis Vaccination manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Encephalitis Vaccination by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Encephalitis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Encephalitis B Vaccine
- Encephalitis Attenuated Live Vaccine
Applications
- Public Hospital
- Private Hospital
- Clinic
- Other
Companies covered
- Novartis
- Sanofi
- Chengdu Institute of Biological Products
- Wuhan Institute of Biological Products
- Lanzhou Institute of Biological Products
- Beijing Taitan
- Valneva
- Bharat Biotech
- Liaoning Chengda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Encephalitis Vaccination Market Size (2021-2032)
- 2.2.2 Global Encephalitis Vaccination Sales (2021-2032)
- 2.2.3 Global Encephalitis Vaccination Market Average Price (2021-2032)
- 2.3 Encephalitis Vaccination by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Encephalitis B Vaccine
- 2.3.3 Encephalitis Attenuated Live Vaccine
- 2.4 Encephalitis Vaccination by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Public Hospital
- 2.4.3 Private Hospital
- 2.4.4 Clinic
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Encephalitis Vaccination Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Encephalitis Vaccination Sales (10K Person-time) of Manufacturers (2021-2026)
- 3.3 Global Encephalitis Vaccination Revenue of Manufacturers (2021-2026)
- 3.4 Global Encephalitis Vaccination Average Price by Manufacturers (2021-2026)
- 3.5 Global Encephalitis Vaccination Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Encephalitis Vaccination, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Encephalitis Vaccination, Product Type & Application
- 3.8 Global Manufacturers of Encephalitis Vaccination, Established Date
- 3.9 Global Encephalitis Vaccination Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Encephalitis Vaccination Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Encephalitis Vaccination Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Chengdu Institute of Biological Products
- 4.3.1 Chengdu Institute of Biological Products Company Information
- 4.3.2 Chengdu Institute of Biological Products Business Overview
- 4.3.3 Chengdu Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolio
- 4.3.5 Chengdu Institute of Biological Products Recent Developments
- 4.4 Wuhan Institute of Biological Products
- 4.4.1 Wuhan Institute of Biological Products Company Information
- 4.4.2 Wuhan Institute of Biological Products Business Overview
- 4.4.3 Wuhan Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolio
- 4.4.5 Wuhan Institute of Biological Products Recent Developments
- 4.5 Lanzhou Institute of Biological Products
- 4.5.1 Lanzhou Institute of Biological Products Company Information
- 4.5.2 Lanzhou Institute of Biological Products Business Overview
- 4.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolio
- 4.5.5 Lanzhou Institute of Biological Products Recent Developments
- 4.6 Beijing Taitan
- 4.6.1 Beijing Taitan Company Information
- 4.6.2 Beijing Taitan Business Overview
- 4.6.3 Beijing Taitan Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Beijing Taitan Encephalitis Vaccination Product Portfolio
- 4.6.5 Beijing Taitan Recent Developments
- 4.7 Valneva
- 4.7.1 Valneva Company Information
- 4.7.2 Valneva Business Overview
- 4.7.3 Valneva Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Valneva Encephalitis Vaccination Product Portfolio
- 4.7.5 Valneva Recent Developments
- 4.8 Bharat Biotech
- 4.8.1 Bharat Biotech Company Information
- 4.8.2 Bharat Biotech Business Overview
- 4.8.3 Bharat Biotech Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bharat Biotech Encephalitis Vaccination Product Portfolio
- 4.8.5 Bharat Biotech Recent Developments
- 4.9 Liaoning Chengda
- 4.9.1 Liaoning Chengda Company Information
- 4.9.2 Liaoning Chengda Business Overview
- 4.9.3 Liaoning Chengda Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Liaoning Chengda Encephalitis Vaccination Product Portfolio
- 4.9.5 Liaoning Chengda Recent Developments
5 Global Encephalitis Vaccination Market Scenario by Region
- 5.1 Global Encephalitis Vaccination Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Encephalitis Vaccination Sales by Region: 2021-2032
- 5.2.1 Global Encephalitis Vaccination Sales by Region: 2021-2026
- 5.2.2 Global Encephalitis Vaccination Sales by Region: 2027-2032
- 5.3 Global Encephalitis Vaccination Revenue by Region: 2021-2032
- 5.3.1 Global Encephalitis Vaccination Revenue by Region: 2021-2026
- 5.3.2 Global Encephalitis Vaccination Revenue by Region: 2027-2032
- 5.4 North America Encephalitis Vaccination Market Facts & Figures by Country
- 5.4.1 North America Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Encephalitis Vaccination Sales by Country (2021-2032)
- 5.4.3 North America Encephalitis Vaccination Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Encephalitis Vaccination Market Facts & Figures by Country
- 5.5.1 Europe Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Encephalitis Vaccination Sales by Country (2021-2032)
- 5.5.3 Europe Encephalitis Vaccination Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Encephalitis Vaccination Market Facts & Figures by Country
- 5.6.1 Asia Pacific Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Encephalitis Vaccination Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Encephalitis Vaccination Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Encephalitis Vaccination Market Facts & Figures by Country
- 5.7.1 South America Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Encephalitis Vaccination Sales by Country (2021-2032)
- 5.7.3 South America Encephalitis Vaccination Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Encephalitis Vaccination Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Encephalitis Vaccination Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Encephalitis Vaccination Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Encephalitis Vaccination Sales by Type (2021-2032)
- 6.1.1 Global Encephalitis Vaccination Sales by Type (2021-2032) & (10K Person-time)
- 6.1.2 Global Encephalitis Vaccination Sales Market Share by Type (2021-2032)
- 6.2 Global Encephalitis Vaccination Revenue by Type (2021-2032)
- 6.2.1 Global Encephalitis Vaccination Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Encephalitis Vaccination Revenue Market Share by Type (2021-2032)
- 6.3 Global Encephalitis Vaccination Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Encephalitis Vaccination Sales by Application (2021-2032)
- 7.1.1 Global Encephalitis Vaccination Sales by Application (2021-2032) & (10K Person-time)
- 7.1.2 Global Encephalitis Vaccination Sales Market Share by Application (2021-2032)
- 7.2 Global Encephalitis Vaccination Revenue by Application (2021-2032)
- 7.2.1 Global Encephalitis Vaccination Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Encephalitis Vaccination Revenue Market Share by Application (2021-2032)
- 7.3 Global Encephalitis Vaccination Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Encephalitis Vaccination Value Chain Analysis
- 8.1.1 Encephalitis Vaccination Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Encephalitis Vaccination Production Mode & Process
- 8.2 Encephalitis Vaccination Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Encephalitis Vaccination Distributors
- 8.2.3 Encephalitis Vaccination Customers
9 Global Encephalitis Vaccination Analyzing Market Dynamics
- 9.1 Encephalitis Vaccination Industry Trends
- 9.2 Encephalitis Vaccination Industry Drivers
- 9.3 Encephalitis Vaccination Industry Opportunities and Challenges
- 9.4 Encephalitis Vaccination Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst